Search Results - Alain Ravaud

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in advanced squamous cell carcinoma of the head and neck: results from a phase I cohort by James L Gulley, Christian Borel, Nicolas Penel, Ahmad Awada, Christoph Helwig, Nicolas Isambert, Byoung Chul Cho, Amaury Daste, Alain Ravaud

    Published in Journal for ImmunoTherapy of Cancer (2020-10-01)
    Get full text
    Article


  2. 2

    Practical Approaches to Patient-Centered Care in Europe: Mixed Methods Study Developing a Conceptual Framework for Comprehensive Cancer Care Networks by Emily Hickmann, Peggy Richter, Hannes Schlieter, Maja Cemazar, Dorota Dudek-Godeau, Nele Grapentin, Ellen Griesshammer, Marjetka Jelenc, Sigita Liutkauskiene, Alain Ravaud, Xavier Troussard, Simone Wesselmann

    Published in JMIR Cancer (2025-07-01)
    Get full text
    Article


  3. 3

    Cost-effectiveness of avelumab first-line maintenance therapy for adult patients with locally advanced or metastatic urothelial carcinoma in France. by Fanny Porte, Anna Granghaud, Jane Chang, Mairead Kearney, Aya Morel, Ingrid Plessala, Hélène Cawston, Julie Roiz, Ying Xiao, Marie-Noelle Solbes, Prisca Lambert, Alain Ravaud, Yohann Loriot, Antoine Thiery-Vuillemin, Pierre Lévy

    Published in PLoS ONE (2024-01-01)
    Get full text
    Article


  4. 4

    Cost-effectiveness of avelumab first-line maintenance therapy for adult patients with locally advanced or metastatic urothelial carcinoma in France by Fanny Porte, Anna Granghaud, Jane Chang, Mairead Kearney, Aya Morel, Ingrid Plessala, Hélène Cawston, Julie Roiz, Ying Xiao, Marie-Noelle Solbes, Prisca Lambert, Alain Ravaud, Yohann Loriot, Antoine Thiery-Vuillemin, Pierre Lévy

    Published in PLoS ONE (2024-01-01)
    Get full text
    Article


  5. 5

    Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis by James L Gulley, Manish R Patel, Keun-Wook Lee, Luc Dirix, Mary Ruisi, Jeffrey R Infante, Patrick Schöffski, Alain Ravaud, Ding Wang, Andrea B Apolo, John A Ellerton, Manish Agrawal, Michael S Gordon, Raid Aljumaily, Theodore Gourdin, Matthew H Taylor, Juliane Manitz, Gregory Pennock

    Published in Journal for ImmunoTherapy of Cancer (2020-10-01)
    Get full text
    Article


  6. 6

    Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma by Laurence Albiges, Bernard Escudier, Gwenaelle Gravis, Ronan Flippot, Alain Ravaud, Maxime Meylan, Nathalie Rioux-Leclercq, Marine Gross-Goupil, Gaëlle Fromont, Christophe Passot, Lionnel Geoffrois, Fréderic Rolland, Manon de Vries-Brilland, Jonathan Dauvé, Elena Spirina-Menand, Christine Chevreau, Ellen Blanc, Félix Lefort, Sylvie Negrier

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Get full text
    Article


  7. 7

    Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a random... by Howard Gurney, Thomas Powles, Asim Amin, Bohuslav Melichar, Camillo Porta, David F McDermott, Toni K Choueiri, Marc-Oliver Grimm, Bernard Escudier, Elizabeth R Plimack, Brian I Rini, Hans J Hammers, Saby George, Robert J Motzer, Alain Ravaud, Osvaldo Arén Frontera, Frede Donskov, Philippe Barthélémy, Viktor Grünwald, Victoria Neiman, Pamela Salman, Christian K Kollmannsberger, Scott S Tykodi, Raya Leibowitz-Amit, Poul F Geertsen, Yoshihiko Tomita, M Brent McHenry, Shruti Shally Saggi, Nizar M Tannir

    Published in Journal for ImmunoTherapy of Cancer (2020-10-01)
    Get full text
    Article


Search Tools: